Logo image of 1ELX.MI

ESTEE LAUDER COMPANIES-CL A (1ELX.MI) Stock Fundamental Analysis

Europe - BIT:1ELX - US5184391044 - Common Stock

81.8 EUR
-3 (-3.54%)
Last: 11/3/2025, 7:00:00 PM
Fundamental Rating

3

1ELX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 13 industry peers in the Personal Care Products industry. Both the profitability and financial health of 1ELX have multiple concerns. 1ELX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year 1ELX was profitable.
In the past year 1ELX had a positive cash flow from operations.
1ELX had positive earnings in 4 of the past 5 years.
1ELX had a positive operating cash flow in each of the past 5 years.
1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCF1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B 3B

1.2 Ratios

The Return On Assets of 1ELX (-5.70%) is worse than 92.31% of its industry peers.
Looking at the Return On Equity, with a value of -29.31%, 1ELX is doing worse than 92.31% of the companies in the same industry.
1ELX's Return On Invested Capital of 4.17% is on the low side compared to the rest of the industry. 1ELX is outperformed by 76.92% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1ELX is significantly below the industry average of 12.37%.
Industry RankSector Rank
ROA -5.7%
ROE -29.31%
ROIC 4.17%
ROA(3y)0.13%
ROA(5y)4.98%
ROE(3y)-1.32%
ROE(5y)17.24%
ROIC(3y)4.98%
ROIC(5y)7.4%
1ELX.MI Yearly ROA, ROE, ROIC1ELX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

1ELX has a Operating Margin of 7.94%. This is in the lower half of the industry: 1ELX underperforms 76.92% of its industry peers.
In the last couple of years the Operating Margin of 1ELX has declined.
1ELX has a better Gross Margin (73.96%) than 76.92% of its industry peers.
1ELX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.94%
PM (TTM) N/A
GM 73.96%
OM growth 3Y-26.29%
OM growth 5Y-11.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-0.3%
1ELX.MI Yearly Profit, Operating, Gross Margins1ELX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

3

2. Health

2.1 Basic Checks

1ELX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for 1ELX has been increased compared to 1 year ago.
1ELX has less shares outstanding than it did 5 years ago.
The debt/assets ratio for 1ELX is higher compared to a year ago.
1ELX.MI Yearly Shares Outstanding1ELX.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
1ELX.MI Yearly Total Debt VS Total Assets1ELX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

1ELX has an Altman-Z score of 3.10. This indicates that 1ELX is financially healthy and has little risk of bankruptcy at the moment.
1ELX's Altman-Z score of 3.10 is in line compared to the rest of the industry. 1ELX outperforms 46.15% of its industry peers.
1ELX has a debt to FCF ratio of 10.92. This is a negative value and a sign of low solvency as 1ELX would need 10.92 years to pay back of all of its debts.
1ELX has a Debt to FCF ratio of 10.92. This is in the lower half of the industry: 1ELX underperforms 76.92% of its industry peers.
1ELX has a Debt/Equity ratio of 1.89. This is a high value indicating a heavy dependency on external financing.
1ELX's Debt to Equity ratio of 1.89 is on the low side compared to the rest of the industry. 1ELX is outperformed by 84.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.89
Debt/FCF 10.92
Altman-Z 3.1
ROIC/WACC0.56
WACC7.46%
1ELX.MI Yearly LT Debt VS Equity VS FCF1ELX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.30 indicates that 1ELX should not have too much problems paying its short term obligations.
The Current ratio of 1ELX (1.30) is better than 61.54% of its industry peers.
1ELX has a Quick Ratio of 1.30. This is a bad value and indicates that 1ELX is not financially healthy enough and could expect problems in meeting its short term obligations.
1ELX's Quick ratio of 0.92 is fine compared to the rest of the industry. 1ELX outperforms 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.92
1ELX.MI Yearly Current Assets VS Current Liabilites1ELX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

4

3. Growth

3.1 Past

1ELX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.31%.
1ELX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -18.22% yearly.
1ELX shows a decrease in Revenue. In the last year, the revenue decreased by -8.24%.
Measured over the past years, 1ELX shows a small growth in Revenue. The Revenue has been growing by 0.04% on average per year.
EPS 1Y (TTM)-42.31%
EPS 3Y-40.77%
EPS 5Y-18.22%
EPS Q2Q%-85.94%
Revenue 1Y (TTM)-8.24%
Revenue growth 3Y-6.88%
Revenue growth 5Y0.04%
Sales Q2Q%-11.96%

3.2 Future

The Earnings Per Share is expected to grow by 27.05% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 2.99% on average over the next years.
EPS Next Y41.92%
EPS Next 2Y40.86%
EPS Next 3Y36.56%
EPS Next 5Y27.05%
Revenue Next Year3.14%
Revenue Next 2Y3.69%
Revenue Next 3Y4.16%
Revenue Next 5Y2.99%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1ELX.MI Yearly Revenue VS Estimates1ELX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
1ELX.MI Yearly EPS VS Estimates1ELX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 62.44, the valuation of 1ELX can be described as expensive.
1ELX's Price/Earnings ratio is rather expensive when compared to the industry. 1ELX is more expensive than 84.62% of the companies in the same industry.
1ELX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.13.
A Price/Forward Earnings ratio of 44.16 indicates a quite expensive valuation of 1ELX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ELX indicates a rather expensive valuation: 1ELX more expensive than 84.62% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.35. 1ELX is valued rather expensively when compared to this.
Industry RankSector Rank
PE 62.44
Fwd PE 44.16
1ELX.MI Price Earnings VS Forward Price Earnings1ELX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ELX indicates a rather expensive valuation: 1ELX more expensive than 92.31% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, 1ELX is valued a bit more expensive than 69.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF 50.56
EV/EBITDA 19.47
1ELX.MI Per share data1ELX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
1ELX's earnings are expected to grow with 36.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.49
PEG (5Y)N/A
EPS Next 2Y40.86%
EPS Next 3Y36.56%

2

5. Dividend

5.1 Amount

1ELX has a Yearly Dividend Yield of 1.41%. Purely for dividend investing, there may be better candidates out there.
The stock price of 1ELX dropped by -42.13% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 2.54, 1ELX is paying slightly less dividend.
With a Dividend Yield of 1.41, 1ELX pays less dividend than the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 1.41%

5.2 History

The dividend of 1ELX has a limited annual growth rate of 4.31%.
Dividend Growth(5Y)4.31%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of 1ELX are negative and hence is the payout ratio. 1ELX will probably not be able to sustain this dividend level.
The dividend of 1ELX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-54.55%
EPS Next 2Y40.86%
EPS Next 3Y36.56%
1ELX.MI Yearly Income VS Free CF VS Dividend1ELX.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

ESTEE LAUDER COMPANIES-CL A

BIT:1ELX (11/3/2025, 7:00:00 PM)

81.8

-3 (-3.54%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-20 2025-08-20/bmo
Earnings (Next)10-30 2025-10-30/bmo
Inst Owners95.71%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap29.48B
Revenue(TTM)14.32B
Net Income(TTM)-1133000000
Analysts69.44
Price Target77.43 (-5.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.41%
Yearly Dividend1.48
Dividend Growth(5Y)4.31%
DP-54.55%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.72%
Min EPS beat(2)0.44%
Max EPS beat(2)99.01%
EPS beat(4)4
Avg EPS beat(4)57.77%
Min EPS beat(4)0.44%
Max EPS beat(4)99.01%
EPS beat(8)8
Avg EPS beat(8)83.43%
EPS beat(12)11
Avg EPS beat(12)80.65%
EPS beat(16)15
Avg EPS beat(16)63.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.31%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)-2.01%
Revenue beat(4)0
Avg Revenue beat(4)-2.46%
Min Revenue beat(4)-3.22%
Max Revenue beat(4)-2.01%
Revenue beat(8)0
Avg Revenue beat(8)-2.21%
Revenue beat(12)1
Avg Revenue beat(12)-1.91%
Revenue beat(16)3
Avg Revenue beat(16)-1.8%
PT rev (1m)6.64%
PT rev (3m)11.74%
EPS NQ rev (1m)4.43%
EPS NQ rev (3m)-26.5%
EPS NY rev (1m)0.17%
EPS NY rev (3m)-6.85%
Revenue NQ rev (1m)0.12%
Revenue NQ rev (3m)1.4%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)1.31%
Valuation
Industry RankSector Rank
PE 62.44
Fwd PE 44.16
P/S 2.37
P/FCF 50.56
P/OCF 26.63
P/B 8.76
P/tB N/A
EV/EBITDA 19.47
EPS(TTM)1.31
EY1.6%
EPS(NY)1.85
Fwd EY2.26%
FCF(TTM)1.62
FCFY1.98%
OCF(TTM)3.07
OCFY3.75%
SpS34.59
BVpS9.33
TBVpS-4.9
PEG (NY)1.49
PEG (5Y)N/A
Graham Number16.59
Profitability
Industry RankSector Rank
ROA -5.7%
ROE -29.31%
ROCE 7.86%
ROIC 4.17%
ROICexc 5.22%
ROICexgc 10.68%
OM 7.94%
PM (TTM) N/A
GM 73.96%
FCFM 4.68%
ROA(3y)0.13%
ROA(5y)4.98%
ROE(3y)-1.32%
ROE(5y)17.24%
ROIC(3y)4.98%
ROIC(5y)7.4%
ROICexc(3y)6.37%
ROICexc(5y)9.94%
ROICexgc(3y)15.14%
ROICexgc(5y)22.74%
ROCE(3y)9.4%
ROCE(5y)13.97%
ROICexgc growth 3Y-33.25%
ROICexgc growth 5Y-18.06%
ROICexc growth 3Y-32.16%
ROICexc growth 5Y-18.64%
OM growth 3Y-26.29%
OM growth 5Y-11.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-0.3%
F-Score4
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 1.89
Debt/FCF 10.92
Debt/EBITDA 3.72
Cap/Depr 72.62%
Cap/Sales 4.2%
Interest Coverage 3.22
Cash Conversion 64.7%
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 0.92
Altman-Z 3.1
F-Score4
WACC7.46%
ROIC/WACC0.56
Cap/Depr(3y)208.69%
Cap/Depr(5y)173.4%
Cap/Sales(3y)10.24%
Cap/Sales(5y)8.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.31%
EPS 3Y-40.77%
EPS 5Y-18.22%
EPS Q2Q%-85.94%
EPS Next Y41.92%
EPS Next 2Y40.86%
EPS Next 3Y36.56%
EPS Next 5Y27.05%
Revenue 1Y (TTM)-8.24%
Revenue growth 3Y-6.88%
Revenue growth 5Y0.04%
Sales Q2Q%-11.96%
Revenue Next Year3.14%
Revenue Next 2Y3.69%
Revenue Next 3Y4.16%
Revenue Next 5Y2.99%
EBIT growth 1Y-27.35%
EBIT growth 3Y-31.36%
EBIT growth 5Y-11.51%
EBIT Next Year102.81%
EBIT Next 3Y38.15%
EBIT Next 5Y28.47%
FCF growth 1Y-53.5%
FCF growth 3Y-30.55%
FCF growth 5Y-16.56%
OCF growth 1Y-46.1%
OCF growth 3Y-25.21%
OCF growth 5Y-11.02%

ESTEE LAUDER COMPANIES-CL A / 1ELX.MI FAQ

What is the ChartMill fundamental rating of ESTEE LAUDER COMPANIES-CL A (1ELX.MI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to 1ELX.MI.


What is the valuation status of ESTEE LAUDER COMPANIES-CL A (1ELX.MI) stock?

ChartMill assigns a valuation rating of 1 / 10 to ESTEE LAUDER COMPANIES-CL A (1ELX.MI). This can be considered as Overvalued.


Can you provide the profitability details for ESTEE LAUDER COMPANIES-CL A?

ESTEE LAUDER COMPANIES-CL A (1ELX.MI) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for 1ELX stock?

The Price/Earnings (PE) ratio for ESTEE LAUDER COMPANIES-CL A (1ELX.MI) is 62.44 and the Price/Book (PB) ratio is 8.76.


Can you provide the expected EPS growth for 1ELX stock?

The Earnings per Share (EPS) of ESTEE LAUDER COMPANIES-CL A (1ELX.MI) is expected to grow by 41.92% in the next year.